Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011168 (
dysphagia
)
15,644
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sporadic ataxia affecting multiple systems, such as cerebellar, extrapyramidal, and autonomic systems, is known as multiple system atrophy cerebellar type (MSA-C), while similar multisystem involvements are seen in certain types of hereditary ataxia, such as spinocerebellar ataxia type 3 (SCA3).
Dysphagia
is a common symptom that can predispose to aspiration pneumonia, a major cause of death in patients with these diseases. Although the progressions of
dysphagia
in patients with
MSA
-C have been reported sporadically, those in SCA3 have not been reported. We retrospectively compared the results of repetitive videofluoroscopic examinations in patients with SCA3 (n = 6) and in those with
MSA
-C (n = 7). The result showed that the gross progression of
dysphagia
was significantly slower in patients with SCA3 than in those with
MSA
-C, but the maximum progression speeds were not significantly different. The
dysphagia
severities were not associated with impaired activity of daily living evaluated by the Barthel index in
MSA
-C, but were associated in SCA3. Despite the small number of patients enrolled, these data suggest that physicians should monitor swallowing functions in patients with SCA3 after mild
dysphagia
develops because it may progress as rapidly as it does in
MSA
-C.
...
PMID:Differential Progression of Dysphagia in Heredity and Sporadic Ataxias Involving Multiple Systems. 2661 69
The addition of posterior cruroplasty to magnetic sphincter augmentation (
MSA
-PC) has been shown to be effective in treating gastroesophageal reflux disease (GERD). This study evaluates the predictors of persistent postoperative
dysphagia
, one of the major complaints after
MSA
-PC. From August 2015 to February 2018 the medical records of 118 patients (male=59, female=59) receiving
MSA
-PC for GERD were reviewed. Postoperative
dysphagia
was present in 80 patients (67.8%), with 20 (16.9%) requiring dilation for persistent
dysphagia
. Three patients (2.5%) had the magnetic sphincter augmentation device removed for persistent
dysphagia
, one was converted to a Nissen fundoplication. The median number of dilations was 1, mean time from surgery to dilation was 5.6 months, and 15/20 (75%) had symptom resolution after 1 to 2 dilations. Dilated patients were more likely than nondilated patients to have atypical GERD symptoms preoperatively (70% vs. 44.7%, P=0.042). After dilation, 93.3% of patients reported a good quality of life.
...
PMID:Postoperative Dysphagia Following Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease. 3228 18